You are here: Industry Insights > HIV

News List

Novel HIV vaccine approach shows promise in “landmark” first-in-human trial europeanpharmaceuticalreview
February 07, 2021
The vaccine was able to target the desired immune cells and could become the first stage of a multi-step vaccine strategy to combat HIV and various other viral diseases.
Gilead, Gritstone Enter Vax Platform Pact for HIV Cure contractpharma
February 02, 2021
Aims to develop HIV-specific vaccine using Gritstone’s prime-boost vaccine platform with antigens developed by Gilead.
US green light for long-acting HIV regimen Cabenuva pharmatimes
January 25, 2021
The US Food and Drug Administration (FDA) has approved ViiV Healthcare and Janssen’s long-acting regimen for HIV-1 infection Cabenuva (cabotegravir, rilpivirine).
US FDA approves ViiV Healthcare’s Cabenuva as complete long-acting regimen for HIV treatment expresspharma
January 22, 2021
Cabenuva allows virologically suppressed adults living with HIV without prior treatment failure or resistance to cabotegravir or rilpivirine to maintain viral suppression with 12 dosing days per year.
ViiV Healthcare continues HIV care partnership with Chelsea and Westminster Hospital pharmatimes
January 19, 2021
ViiV Healthcare, a GlaxoSmithKline company, is continuing a partnership with Chelsea and Westminster Hospital NHS Foundation Trust to ‘transform’ HIV patient care with digital technology.
Strides gets USFDA approval for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets expresspharma
January 15, 2021
The combination of Emtricitabine and Tenofovir slows down the spread of HIV in the body and is used along with other medications to treat HIV in adults and children.
European Commission approves dispersible tablets to treat paediatric HIV europeanpharmaceuticalreview
January 14, 2021
Marketing authorisation in the EU has been given to Tivicay (dolutegravir) dispersible tablets to treat HIV in certain paediatric patients.
First long-acting HIV treatment approved in Europe europeanpharmaceuticalreview
January 05, 2021
The European Commission approval of the long-acting injectable HIV treatment could transform the lives of people living with the disease.
EU nod for first long-acting HIV injectable treatment pharmatimes
December 22, 2020
The European Commission (EC) has authorised Janssen’s Rekambys (rilpivirine injection) in combination with ViiV Healthcare’s Vocabria (cabotegravir injection and tablets) to treat HIV-1 infections in adults who are virologically suppressed.
Cameo Expands Partnership with (RED) to Fight AIDS and COVID-19 on World AIDS Day & #GivingTuesday prnewswire
December 02, 2020
This World AIDS Day, Cameo, the platform enabling fans to connect with their favorite talent worldwide, will launch its second year of partnership with (RED) to fight AIDS, and this year also COVID-19, as part of (RED)'s Shopathon campaign.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 24 25 Next page